Abbott Labs Earnings, Revenue beat In Q4

  • Investing.com
  • Stock Market News
Abbott Labs Earnings, Revenue beat In Q4

Investing.com - Abbott Labs (NYSE: ABT ) reported on Wednesday fourth quarter earnings that beat analysts' forecasts and revenue that topped expectations.

Abbott Labs announced earnings per share of $1.32 on revenue of $11.47B. Analysts polled by Investing.com anticipated EPS of $1.21 on revenue of $10.66B.

Abbott Labs shares are up 1% from the beginning of the year and are trading at $122.50 , down-from-52-week-high.They are outperforming the S&P 500 which is down 8.6% from the start of the year.

Abbott Labs shares lost 0.62% in pre-market trade the report.

Abbott Labs follows other major Healthcare sector earnings this month

Abbott Labs's report follows an earnings beat by J&J on Tuesday, who reported EPS of $2.13 on revenue of $24.8B, compared to forecasts EPS of $2.12 on revenue of $25.28B.

UnitedHealth had beat expectations on Wednesday, January 19, 2022 with fourth quarter EPS of $4.48 on revenue of $73.74B, compared to forecast for EPS of $4.3 on revenue of $72.98B.

Stay up-to-date on all of the upcoming earnings reports by visiting Investing.com's earnings calendar

Drop an image here or Supported formats: *.jpg, *.png, *.gif up to 5mb

Error: File type not supported

Drop an image here or

100